Literature DB >> 23747016

Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.

Delin Chen1, Ning Kon, Jiayun Zhong, Pingzhao Zhang, Long Yu, Wei Gu.   

Abstract

ARF suppresses aberrant cell growth upon c-Myc overexpression by activating p53 responses. Nevertheless, the precise mechanism by which ARF specifically restrains the oncogenic potential of c-Myc without affecting its normal physiological function is not well understood. Here, we show that low levels of c-Myc expression stimulate cell proliferation, whereas high levels inhibit by activating the ARF/p53 response. Although the mRNA levels of ARF are induced in both scenarios, the accumulation of ARF protein occurs only when ULF-mediated degradation of ARF is inhibited by c-Myc overexpression. Moreover, the levels of ARF are reduced through ULF-mediated ubiquitination upon DNA damage. Blocking ARF degradation by c-Myc overexpression dramatically stimulates the apoptotic responses. Our study reveals that ARF stability control is crucial for differentiating normal (low) versus oncogenic (high) levels of c-Myc expression and suggests that differential effects on ULF- mediated ARF ubiquitination by c-Myc levels act as a barrier in oncogene-induced stress responses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747016      PMCID: PMC3841012          DOI: 10.1016/j.molcel.2013.05.006

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  44 in total

1.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

Authors:  M K Mateyak; A J Obaya; S Adachi; J M Sedivy
Journal:  Cell Growth Differ       Date:  1997-10

2.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

3.  Arf induces p53-dependent and -independent antiproliferative genes.

Authors:  Mei-Ling Kuo; Eric J Duncavage; Rose Mathew; Willem den Besten; Deqing Pei; Deanna Naeve; Tadashi Yamamoto; Cheng Cheng; Charles J Sherr; Martine F Roussel
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

4.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

5.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

Review 6.  Telomeres, stem cells, senescence, and cancer.

Authors:  Norman E Sharpless; Ronald A DePinho
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.

Authors:  Troy A Baudino; Catriona McKay; Helene Pendeville-Samain; Jonas A Nilsson; Kirsteen H Maclean; Elsie L White; Ann C Davis; James N Ihle; John L Cleveland
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

8.  N-terminal polyubiquitination and degradation of the Arf tumor suppressor.

Authors:  Mei-Ling Kuo; Willem den Besten; David Bertwistle; Martine F Roussel; Charles J Sherr
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

9.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  32 in total

1.  MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures.

Authors:  Heidi M Haikala; Juha Klefström; Martin Eilers; Katrin E Wiese
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

Authors:  G Y Wang; C N Wood; J A Dolorito; E Libove; E H Epstein
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

3.  In the race for protection, ARF comes second.

Authors:  L Golomb; M Oren
Journal:  Cell Death Differ       Date:  2013-11       Impact factor: 15.828

4.  MKK7 and ARF: new players in the DNA damage response scenery.

Authors:  Athanassios Kotsinas; Panagiota Papanagnou; Panagiotis Galanos; Daniel Schramek; Paul Townsend; Josef M Penninger; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

Review 5.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

6.  Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells.

Authors:  Yiping Wang; Xiangdong Cheng; Muhammad Kaleem Samma; Sam K P Kung; Clement M Lee; Sung Kay Chiu
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

7.  The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.

Authors:  Megan Romeo; Tetiana Hutchison; Aditi Malu; Averi White; Janice Kim; Rachel Gardner; Katie Smith; Katherine Nelson; Rachel Bergeson; Ryan McKee; Carolyn Harrod; Lee Ratner; Bernhard Lüscher; Ernest Martinez; Robert Harrod
Journal:  Virology       Date:  2018-02-20       Impact factor: 3.616

8.  Repression of SRF target genes is critical for Myc-dependent apoptosis of epithelial cells.

Authors:  Katrin E Wiese; Heidi M Haikala; Björn von Eyss; Elmar Wolf; Cyril Esnault; Andreas Rosenwald; Richard Treisman; Juha Klefström; Martin Eilers
Journal:  EMBO J       Date:  2015-04-20       Impact factor: 11.598

Review 9.  Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2016-05-03       Impact factor: 4.304

10.  TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.

Authors:  L Wang; P Zhang; D P Molkentine; C Chen; J M Molkentine; H Piao; U Raju; J Zhang; D R Valdecanas; R C Tailor; H D Thames; T A Buchholz; J Chen; L Ma; K A Mason; K-K Ang; R E Meyn; H D Skinner
Journal:  Oncogene       Date:  2016-07-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.